2017
DOI: 10.4067/s0034-98872017000300010
|View full text |Cite
|
Sign up to set email alerts
|

Potencial uso terapéutico de cannabis

Abstract: (Rev Med Chile 2017; 145: 360-367)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
5

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 40 publications
0
5
0
5
Order By: Relevance
“…Here, types CB 1 and CB 2 predominate, and can be found in a high number of brain areas of the basal ganglia, hippocampus, cerebellum, frontal neocortical, cortex frontal, and the anterior cingulate. In this sense, research studied should focus on the development of medicines that act on receptors CB 1 and CB 2 , as they seem to cause certain speci c therapeutic effects, as the antiepileptic, analgesic, anti-in ammatory, among others (Avello et al, 2017;Burns et al, 2007;Castro et al, 2016;Cavuoto et al, 2007;Crean et al, 2011;Eldreth et al, 2004;Herkenham et al, 1991;Matsuda, 1990;Mackie, 2008;Sevy et al, 2008;Iversen, 2003) For the reasons above exposed, the purpose of this exploratory re ective study emerges as a basis to foster higher awareness on the effects of THC consumption. The following research question is then posed:…”
Section: Social Responsibility and Integral Educationmentioning
confidence: 99%
“…Here, types CB 1 and CB 2 predominate, and can be found in a high number of brain areas of the basal ganglia, hippocampus, cerebellum, frontal neocortical, cortex frontal, and the anterior cingulate. In this sense, research studied should focus on the development of medicines that act on receptors CB 1 and CB 2 , as they seem to cause certain speci c therapeutic effects, as the antiepileptic, analgesic, anti-in ammatory, among others (Avello et al, 2017;Burns et al, 2007;Castro et al, 2016;Cavuoto et al, 2007;Crean et al, 2011;Eldreth et al, 2004;Herkenham et al, 1991;Matsuda, 1990;Mackie, 2008;Sevy et al, 2008;Iversen, 2003) For the reasons above exposed, the purpose of this exploratory re ective study emerges as a basis to foster higher awareness on the effects of THC consumption. The following research question is then posed:…”
Section: Social Responsibility and Integral Educationmentioning
confidence: 99%
“…CB 2 R was thought to be primarily expressed in microglial cells, especially activated microglial cells [41]. However, this theory has been challenged by recent studies that have found CB 2 R expressed in numerous brain areas [42,43], including ventral tegmental area dopaminergic neurons [44], which also express CB 1 R [45]. Dopaminergic CB 2 R plays an important role in modulating dopaminergic neuronal activity and dopaminerelated functions [44], inhibiting psychomotor behaviors, and altering anxiety, depression, alcohol dependence [46], and cacaine-induced locomotor-stimulating effects [47].…”
Section: The Endocannabinoid Systemmentioning
confidence: 99%
“…Among the most important endogenous cannabinoid (ECs) neurotransmitter is arachidonoyl ethanolamide (or anandamide -AEA), [1,7] being agonists of such receptor [8].…”
Section: Introductionmentioning
confidence: 99%
“…If it is presynaptic and with adenylate Cyclase inhibition, it may be generated hyperpolarization with a consequent decrease in neurotransmitter release. If it is postsynaptic, the action of rCB1 is on K + channel regulation and adenylate cyclase inhibition [7,9]. The neuromodulatory action of AEA is due to the following characteristics: they have distinct synthetic pathways; their cell release occurs after membrane depolarization and calcium intake; and its action is terminated with its reuptake and degradation by an intracellular enzyme (fatty acid amide hydrolase) [10].…”
Section: Introductionmentioning
confidence: 99%